Akoya Biosciences Revenue vs. Current Valuation
| AKYA Stock | USD 3.13 0.08 2.49% |
Total Revenue | First Reported 2010-12-31 | Previous Quarter 96.6 M | Current Value 68.4 M | Quarterly Volatility 16.5 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.66 | 0.5827 |
|
|
For Akoya Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Akoya Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Akoya Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Akoya Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Akoya Biosciences over time as well as its relative position and ranking within its peers.
Akoya |
Akoya Biosciences' Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akoya Biosciences. If investors know Akoya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akoya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Revenue Per Share 1.889 | Quarterly Revenue Growth (0.01) | Return On Assets (0.18) | Return On Equity (1.28) |
The market value of Akoya Biosciences is measured differently than its book value, which is the value of Akoya that is recorded on the company's balance sheet. Investors also form their own opinion of Akoya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Akoya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akoya Biosciences' market value can be influenced by many factors that don't directly affect Akoya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akoya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akoya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akoya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Akoya Biosciences Current Valuation vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Akoya Biosciences's current stock value. Our valuation model uses many indicators to compare Akoya Biosciences value to that of its competitors to determine the firm's financial worth. Akoya Biosciences is rated below average in revenue category among its peers. It also is rated below average in current valuation category among its peers reporting about 2.01 of Current Valuation per Revenue. At present, Akoya Biosciences' Total Revenue is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Akoya Biosciences' earnings, one of the primary drivers of an investment's value.Akoya Biosciences' Earnings Breakdown by Geography
Akoya Revenue vs. Competition
Akoya Biosciences is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 12.05 Billion. Akoya Biosciences maintains roughly 96.63 Million in revenue contributing less than 1% to equities under Health Care industry.
Akoya Current Valuation vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Akoya Biosciences |
| = | 96.63 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Akoya Biosciences |
| = | 194.41 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Akoya Current Valuation vs Competition
Akoya Biosciences is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 51.76 Billion. Akoya Biosciences adds roughly 194.41 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Akoya Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Akoya Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Akoya Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Akoya Biosciences' change in net profit over the period of time. It can combine multiple indicators of Akoya Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -5.4 K | -5.7 K | |
| Net Interest Income | -5.2 M | -5.4 M | |
| Operating Income | -56 M | -58.8 M | |
| Net Loss | -71.4 M | -67.8 M | |
| Income Before Tax | -63.3 M | -66.4 M | |
| Total Other Income Expense Net | -7.3 M | -7.6 M | |
| Net Loss | -63.6 M | -60.4 M | |
| Net Loss | -63.3 M | -66.5 M | |
| Income Tax Expense | 40 K | 41.4 K | |
| Interest Income | 3.1 M | 3.3 M | |
| Non Operating Income Net Other | 163.3 K | 171.5 K | |
| Change To Netincome | 8.6 M | 4.6 M | |
| Net Loss | (1.43) | (1.50) | |
| Income Quality | 0.80 | 0.60 | |
| Net Income Per E B T | 1.00 | 1.10 |
Akoya Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Akoya Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Akoya Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Akoya Biosciences' important profitability drivers and their relationship over time.
Use Akoya Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Akoya Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akoya Biosciences will appreciate offsetting losses from the drop in the long position's value.Akoya Biosciences Pair Trading
Akoya Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Akoya Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Akoya Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Akoya Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Akoya Biosciences to buy it.
The correlation of Akoya Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akoya Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akoya Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Akoya Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Akoya Biosciences position
In addition to having Akoya Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run High Yield ETFs Thematic Idea Now
High Yield ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The High Yield ETFs theme has 103 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize High Yield ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
To fully project Akoya Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Akoya Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Akoya Biosciences' income statement, its balance sheet, and the statement of cash flows.